AAAAAA

   
Results: 1-15 |
Results: 15
Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome - Clinical results, neuropsychological effects, and cost-effectiveness
Authors: Majoie, HJM Berfelo, MW Aldenkamp, AP Evers, SMAA Kessels, AGH Renier, WO
Citation: Hjm. Majoie et al., Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome - Clinical results, neuropsychological effects, and cost-effectiveness, J CL NEURPH, 18(5), 2001, pp. 419-428
Long-term treatment retention with topiramate
Authors: Deckers, CLP Renier, WO
Citation: Clp. Deckers et Wo. Renier, Long-term treatment retention with topiramate, EPILEPSIA, 42(2), 2001, pp. 290-290
A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome
Authors: Tranebjaerg, L Hamel, BCJ Gabreels, FJM Renier, WO Van Ghelue, M
Citation: L. Tranebjaerg et al., A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome, EUR J HUM G, 8(6), 2000, pp. 464-467
Human absence epilepsy: The WAG/Rij rat as a model
Authors: Renier, WO Coenen, AML
Citation: Wo. Renier et Aml. Coenen, Human absence epilepsy: The WAG/Rij rat as a model, NEUROSC R C, 26(3), 2000, pp. 181-191
Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy. (vol 30, pg 320, 1999)
Authors: Strijks, E Poort, SR Renier, WO Gabreels, FJM Bertina, RM
Citation: E. Strijks et al., Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy. (vol 30, pg 320, 1999), NEUROPEDIAT, 31(4), 2000, pp. 223-223
Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten
Authors: Deckers, CLP Hekster, YA Keyser, A Meinardi, H Renier, WO
Citation: Clp. Deckers et al., Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten, NEUROLOGY, 55(1), 2000, pp. 154-155
Selection of antiepileptic drug polytherapy based on mechanisms of action:The evidence reviewed
Authors: Deckers, CLP Czuczwar, SJ Hekster, YA Keyser, A Kubova, H Meinardi, H Patsalos, PN Renier, WO Van Rijn, CM
Citation: Clp. Deckers et al., Selection of antiepileptic drug polytherapy based on mechanisms of action:The evidence reviewed, EPILEPSIA, 41(11), 2000, pp. 1364-1374
Four novel mutations in the Tyrosine Hydroxylase gene in patients with infantile parkinsonism
Authors: Swaans, RJM Rondot, P Renier, WO Van den Heuvel, LPWJ Steenbergen-Spanjers, GCH Wevers, RA
Citation: Rjm. Swaans et al., Four novel mutations in the Tyrosine Hydroxylase gene in patients with infantile parkinsonism, ANN HUM GEN, 64, 2000, pp. 25-31
Follow-up of psychogenic, non-epileptic seizures: a pilot study - experience in a Dutch special centre for epilepsy
Authors: Jongsma, MJ Mommers, JM Renier, WO Meinardi, H
Citation: Mj. Jongsma et al., Follow-up of psychogenic, non-epileptic seizures: a pilot study - experience in a Dutch special centre for epilepsy, SEIZURE-E J, 8(3), 1999, pp. 146-148
The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF81297
Authors: Andringa, G Vermeulen, RJ Drukarch, B Renier, WO Stoof, JC Cools, AR
Citation: G. Andringa et al., The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF81297, BEHAV PHARM, 10(2), 1999, pp. 163-173
D-2-hydroxyglutaric aciduria: Biochemical marker or clinical disease entity?
Authors: van der Knaap, MS Jakobs, C Hoffmann, GF Nyhan, WL Renier, WO Smeitink, JAM Catsman-Berrevoets, CE Hjalmarson, O Vallance, H Sugita, K Bowe, CM Herrin, JT Craigen, WJ Buist, NRM Brookfield, DSK Chalmers, RA
Citation: Ms. Van Der Knaap et al., D-2-hydroxyglutaric aciduria: Biochemical marker or clinical disease entity?, ANN NEUROL, 45(1), 1999, pp. 111-119
A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome
Authors: De Coo, IFM Renier, WO Ruitenbeek, W Ter Laak, HJ Bakker, M Schagger, H Van Oost, BA Smeets, HJM
Citation: Ifm. De Coo et al., A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome, ANN NEUROL, 45(1), 1999, pp. 130-133
Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy
Authors: Strijks, E Poort, SR Renier, WO Gabreels, FJM Bertina, RM
Citation: E. Strijks et al., Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy, NEUROPEDIAT, 30(6), 1999, pp. 320-324
A new X linked neurodegenerative syndrome with metal retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region (vol 36, pg 140, 1999)
Authors: Hamel, BCJ Wesseling, P Renier, WO van den Helm, B Ropers, HH Kremer, H Mariman, ECM
Citation: Bcj. Hamel et al., A new X linked neurodegenerative syndrome with metal retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region (vol 36, pg 140, 1999), J MED GENET, 36(8), 1999, pp. 654-654
A new X linked neurodegenerative syndrome with mental retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region
Authors: Hamel, BCJ Wesseling, P Renier, WO van den Helm, B Ropers, HH Kremer, H Mariman, ECM
Citation: Bcj. Hamel et al., A new X linked neurodegenerative syndrome with mental retardation, blindness, convulsions, spasticity, mild hypomyelination, and early death maps to the pericentromeric region, J MED GENET, 36(2), 1999, pp. 140-143
Risultati: 1-15 |